Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Alexion Pharmaceuticals, Inc.
9.5% sales growth and 8.92% return on equity
Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products.
Alexion Pharmaceuticals, Inc.'s sales growth this year is anticipated to be 20.8% and 9.3% for next year.
Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 5.86B for the twelve trailing months.
Alexion Pharmaceuticals, Inc.'s sales growth for the next quarter is 9.5%. The company's growth estimates for the current quarter and the next is a negative 5.5% and negative -3.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.92%.
Alexion Pharmaceuticals, Inc.'s Stock Yearly Top and Bottom Value
Alexion Pharmaceuticals, Inc.'s stock is valued at $154.83 at 07:22 EST, under its 52-week high of $160.03 and way above its 52-week low of $72.67.
Alexion Pharmaceuticals, Inc.'s Moving Average
Alexion Pharmaceuticals, Inc.'s value is way higher than its 50-day moving average of $127.79 and way above its 200-day moving average of $115.55.Previous days news about Alexion Pharmaceuticals, Inc.
Shareholder alert: monteverde & associates PC announces an investigation of alexion pharmaceuticals, inc. - ALXN. According to Business Insider on Sat Dec 19, "The investigation focuses on whether Alexion Pharmaceuticals, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, 2) whether and by how much this proposed transaction undervalues the Company, and 3) whether all material information has been disclosed.", "Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (ALXN) relating to its proposed acquisition by AstraZeneca, PLC. "
2. Black Hills Corporation
14.8% sales growth and 9.31% return on equity
Black Hills Corporation, through its subsidiaries, operates as an electric and natural gas utility company in the United States.
Black Hills Corporation's sales growth this year is anticipated to be 6.5% and 8.8% for next year.
Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 1.69B for the twelve trailing months.
Black Hills Corporation's sales growth for the next quarter is 14.8%. The company's growth estimates for the ongoing quarter and the next is 0.9% and 5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.31%.
Black Hills Corporation's Stock Yearly Top and Bottom Value
Black Hills Corporation's stock is valued at $60.69 at 07:22 EST, way under its 52-week high of $87.12 and way above its 52-week low of $48.07.
Black Hills Corporation's Moving Average
Black Hills Corporation's value is under its 50-day moving average of $61.02 and higher than its 200-day moving average of $58.22.3. Unity Bancorp, Inc.
13% sales growth and 13.83% return on equity
Unity Bancorp, Inc. operates as the holding company for Unity Bank that provides commercial and retail banking products and services to individuals, small and medium sized businesses, and professional communities.
Unity Bancorp, Inc.'s sales growth this year is anticipated to be 12.2% and 5.4% for next year.
Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 65.69M for the twelve trailing months.
Unity Bancorp, Inc.'s sales growth for the next quarter is 13%. The company's growth estimates for the ongoing quarter and the next is 3.6% and 26.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.83%.
Unity Bancorp, Inc.'s Stock Yearly Top and Bottom Value
Unity Bancorp, Inc.'s stock is valued at $18.05 at 07:22 EST, way under its 52-week high of $24.15 and way higher than its 52-week low of $8.76.
Unity Bancorp, Inc.'s Moving Average
Unity Bancorp, Inc.'s value is higher than its 50-day moving average of $16.58 and way above its 200-day moving average of $14.20.4. Activision Blizzard, Inc
10.6% sales growth and 16.63% return on equity
Activision Blizzard, Inc., together with its subsidiaries, develops and distributes content and services on video game consoles, personal computers (PC), and mobile devices in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Activision Blizzard, Inc's sales growth this year is anticipated to be 27.7% and 2% for next year.
Year-on-year quarterly revenue growth grew by 52.4%, now sitting on 7.66B for the twelve trailing months.
Activision Blizzard, Inc's sales growth for the next quarter is 10.6%. The company's growth estimates for the ongoing quarter and the next is a negative 5.7% and 6.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.63%.
Activision Blizzard, Inc's Stock Yearly Top and Bottom Value
Activision Blizzard, Inc's stock is valued at $88.81 at 07:22 EST, below its 52-week high of $90.78 and way above its 52-week low of $50.51.
Activision Blizzard, Inc's Moving Average
Activision Blizzard, Inc's worth is way higher than its 50-day moving average of $79.83 and way higher than its 200-day moving average of $79.64.5. BMC Stock Holdings, Inc.
12.8% sales growth and 12.69% return on equity
BMC Stock Holdings, Inc., together with its subsidiaries, provides various building products and services for homebuilder and professional contractor customers in the United States.
BMC Stock Holdings, Inc.'s sales growth this year is anticipated to be 14.2% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 13.1%, now sitting on 3.88B for the twelve trailing months.
BMC Stock Holdings, Inc.'s sales growth for the next quarter is 12.8%. The company's growth estimates for the current quarter and the next is 86.5% and 45%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.69%.
BMC Stock Holdings, Inc.'s Stock Yearly Top and Bottom Value
BMC Stock Holdings, Inc.'s stock is valued at $46.38 at 07:22 EST, below its 52-week high of $50.26 and way above its 52-week low of $13.38.